Danaher Corporation Strengthens Diagnostics Offerings with $4B Acquisition of Cepheid

Danaher Corporation has announced the acquisition of medical diagnostics company Cepheid, strengthening their presence in the Molecular Diagnostics market. Danaher will pay $53 per share in cash, a premium of